Securities fraud litigation history and active cases
In Litigation
0
Settlement
1
Closed
0
Total Settlement
$69M
4:21cv3343 • May 5, 2021
Class Period Start
November 26, 2019
Class Period End
August 4, 2021
PSLRA Deadline
July 6, 2021
Case Allegations
10b5
Statutes of Repose
Nov 26, 2022
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
October 1, 2026
Settlement Fund
$69,000,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) from November 26, 2019 through May 6, 2021, inclusive.
Claim Administrator
Kroll Settlement Administration
P.O. Box 5013
New York, NY 10150-5013
+1 833-522-2606
[email protected]
Settlement Website
https://www.chemocentryxsecuritieslitigation.com/Hearing Date
October 29, 2026
Opt-out Deadline
December 31, 1969
Settlement Note
Download hereProof Of Claim
Download here4:21cv3343 • May 5, 2021
Class Period Start
November 26, 2019
Class Period End
August 4, 2021
PSLRA Deadline
July 6, 2021
Case Allegations
10b5
Statutes of Repose
Nov 26, 2022
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
October 1, 2026
Settlement Fund
$69,000,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) from November 26, 2019 through May 6, 2021, inclusive.
Claim Administrator
Kroll Settlement Administration
P.O. Box 5013
New York, NY 10150-5013
+1 833-522-2606
[email protected]
Settlement Website
https://www.chemocentryxsecuritieslitigation.com/Hearing Date
October 29, 2026
Opt-out Deadline
December 31, 1969
Settlement Note
Download hereProof Of Claim
Download hereTOP